as of 05-04-2026 3:37pm EST
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
| Founded: | 1920 | Country: | United States |
| Employees: | N/A | City: | KINGSPORT |
| Market Cap: | 8.0B | IPO Year: | 1996 |
| Target Price: | $79.31 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 0.93 | EPS Growth: | -46.54 |
| 52 Week Low/High: | $56.11 - $83.47 | Next Earning Date: | 04-30-2026 |
| Revenue: | $8,752,000,000 | Revenue Growth: | -6.71% |
| Revenue Growth (this year): | 3.06% | Revenue Growth (next year): | 3.47% |
| P/E Ratio: | 18.79 | Index: | N/A |
| Free Cash Flow: | 424.0M | FCF Growth: | -38.37% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
SEC 8-K filings with transcript text
Jan 29, 2026 · 100% conf.
1D
+3.54%
$71.43
Act: +0.46%
5D
+5.70%
$72.92
Act: +10.28%
20D
+7.05%
$73.86
Act: +9.39%
emn-202601290000915389false00009153892026-01-292026-01-290000915389us-gaap:CommonStockMember2026-01-292026-01-290000915389emn:A1.875notesdueNovember2026Member2026-01-292026-01-29
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 29, 2026
(Exact Name of Registrant as Specified in Its Charter)
Delaware 1-12626 62-1539359 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
200 South Wilcox Drive KingsportTennessee37662 (Address of Principal Executive Offices)(Zip Code)
(423) 229-2000 (Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per share EMNNew York Stock Exchange 1.875% Notes Due 2026EMN26New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On January 29, 2026, the registrant publicly released its financial results for fourth quarter 2025. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits:
(d) Exhibits
The following exhibits are furnished pursuant to Item 9.01:
99.01 Public release by Eastman on January 29, 2026 of fourth quarter 2025 financial results
104 Cover Page Interactive Data File
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company
By:/s/ Michelle R. Stewart
Michelle R. Stewart Vice President, Chief Accounting Officer and Corporate Controller Date: January 29, 2026
Nov 3, 2025
emn-202511030000915389false00009153892025-11-032025-11-030000915389us-gaap:CommonStockMember2025-11-032025-11-030000915389emn:A1.875notesdueNovember2026Member2025-11-032025-11-03
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 3, 2025
(Exact Name of Registrant as Specified in Its Charter)
Delaware 1-12626 62-1539359 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
200 South Wilcox Drive KingsportTennessee37662 (Address of Principal Executive Offices)(Zip Code)
(423) 229-2000 (Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per share EMNNew York Stock Exchange 1.875% Notes Due 2026EMN26New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On November 3, 2025, the registrant publicly released its financial results for third quarter 2025. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits:
(d) Exhibits
The following exhibits are furnished pursuant to Item 9.01:
99.01 Public release by Eastman on November 3, 2025 of third quarter 2025 financial results
104 Cover Page Interactive Data File
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company
By:/s/ Michelle R. Stewart
Michelle R. Stewart Vice President, Chief Accounting Officer and Corporate Controller Date: November 3, 2025
Jul 31, 2025
emn-202507310000915389false00009153892025-07-312025-07-310000915389us-gaap:CommonStockMember2025-07-312025-07-310000915389emn:A1.875notesdueNovember2026Member2025-07-312025-07-31
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 31, 2025
(Exact Name of Registrant as Specified in Its Charter)
Delaware 1-12626 62-1539359 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
200 South Wilcox Drive KingsportTennessee37662 (Address of Principal Executive Offices)(Zip Code)
(423) 229-2000 (Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s)Name of each exchange on which registered Common Stock, par value $0.01 per share EMNNew York Stock Exchange 1.875% Notes Due 2026EMN26New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
On July 31, 2025, the registrant publicly released its financial results for second quarter 2025. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits:
(d) Exhibits
The following exhibits are furnished pursuant to Item 9.01:
99.01 Public release by Eastman on July 31, 2025 of second quarter 2025 financial results
104 Cover Page Interactive Data File
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company
By:/s/ Michelle R. Stewart
Michelle R. Stewart Vice President, Chief Accounting Officer and Corporate Controller Date: July 31, 2025
See how EMN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "EMN Eastman Chemical Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.